The secretory peptidase inhibitor R3HDML fine-tunes p38 MAPK signaling to maintain glomerular basement membrane architecture during renal aging and disease
Abstract
Serine proteases and their inhibitors are the most abundant class of proteolytic enzymes, involved in numerous biological processes such as cellular crosstalk. However, their role in renal diseases remains controversial. In this study, we identified the putative serine peptidase inhibitor R3HDML as a podocyte-specific expressed and secreted protein. CRISPR/Cas9-mediated generation of a novel floxed- R3hdml allele, demonstrated a regulatory function in renal aging and diabetic nephropathy. R3hdml knockout mice developed hump-like collagen IV deposits in the glomerular basement membrane (GBM), as well as mesangial expansion. These deposits induced the retraction of podocyte protrusions and the formation of a clustered, synaptopodin-positive actin cytoskeleton via integrin adhesion signaling. Despite the development of these key podocytopathy features, renal function was not severely impaired by the loss of R3hdml in aging, diabetic nephropathy, and during ischemia-reperfusion induced tubular injury and regeneration. Interaction proteomics revealed p38 MAPK signaling-related kinases, collagen modifiers, and N-terminal signaling peptide containing proteins, as potential R3HDML interactors. Consequently, Thr180/Tyr182 phosphorylation of p38 MAPK and downstream collagen IV deposition were suppressed by R3HDML in podocytes. In summary, we demonstrate a cell type specific mechanism by which podocytes maintain the composition and structure of the GBM in ageing and disease.
Related
- Hepatic biomarker trajectories and mortality in septic adults with type 2 diabetes and recorded dipeptidyl peptidase-4 inhibitor exposure versus metformin-based therapy: A propensity-score-matched cohort study.
- Conserved neuronal-like and secretory programs define the spatial architecture of gastroenteropancreatic neuroendocrine tumors
- A Multi-Kinase Inhibitor Screen Identifies mTOR Signaling as a Vulnerability in Advanced Prostate Cancer.
- MAPK signaling links BRD2 chromatin occupancy to PI3K/AKT inhibitor sensitivity
- Sodium-glucose cotransporter 2 inhibitor tofogliflozin ameliorates insulin signaling by improving mitochondrial function in the podocytes in DKD
BibTeX
@article{rogg2026secretory,
title = {{The secretory peptidase inhibitor R3HDML fine-tunes p38 MAPK signaling to maintain glomerular basement membrane architecture during renal aging and disease}},
author = {Manuel Rogg and Christoph Schell and Ann-Kathrin Scherzinger and Julia Keller and Charlotte Meyer and Stefan Tholen and Charlotte Kark and Melanie Boerries and Martin Helmstädter and Oliver Schilling and Tobias B. Huber and Wibke Bechtel-Walz},
journal = {Scientific Reports},
year = {2026},
month = oct,
doi = {10.1038/s41598-026-77117-0},
url = {https://www.nature.com/articles/s41598-026-77117-0},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - The secretory peptidase inhibitor R3HDML fine-tunes p38 MAPK signaling to maintain glomerular basement membrane architecture during renal aging and disease
AU - Manuel Rogg
AU - Christoph Schell
AU - Ann-Kathrin Scherzinger
AU - Julia Keller
AU - Charlotte Meyer
AU - Stefan Tholen
AU - Charlotte Kark
AU - Melanie Boerries
AU - Martin Helmstädter
AU - Oliver Schilling
AU - Tobias B. Huber
AU - Wibke Bechtel-Walz
PY - 2026
DA - 2026/10/25
JO - Scientific Reports
DO - 10.1038/s41598-026-77117-0
UR - https://www.nature.com/articles/s41598-026-77117-0
AB - Serine proteases and their inhibitors are the most abundant class of proteolytic enzymes, involved in numerous biological processes such as cellular crosstalk. However, their role in renal diseases remains controversial. In this study, we identified the putative serine peptidase inhibitor R3HDML as a podocyte-specific expressed and secreted protein. CRISPR/Cas9-mediated generation of a novel floxed- R3hdml allele, demonstrated a regulatory function in renal aging and diabetic nephropathy. R3hdml knockout mice developed hump-like collagen IV deposits in the glomerular basement membrane (GBM), as well as mesangial expansion. These deposits induced the retraction of podocyte protrusions and the formation of a clustered, synaptopodin-positive actin cytoskeleton via integrin adhesion signaling. Despite the development of these key podocytopathy features, renal function was not severely impaired by the loss of R3hdml in aging, diabetic nephropathy, and during ischemia-reperfusion induced tubular injury and regeneration. Interaction proteomics revealed p38 MAPK signaling-related kinases, collagen modifiers, and N-terminal signaling peptide containing proteins, as potential R3HDML interactors. Consequently, Thr180/Tyr182 phosphorylation of p38 MAPK and downstream collagen IV deposition were suppressed by R3HDML in podocytes. In summary, we demonstrate a cell type specific mechanism by which podocytes maintain the composition and structure of the GBM in ageing and disease.
SN - 2045-2322
ER -